Bristol-Myers Squibb Company (BCBA:BMY)

Argentina flag Argentina · Delayed Price · Currency is ARS
19,375
0.00 (0.00%)
At close: Jul 4, 2025, 5:00 PM BRT
14.46%
Market Cap 120.33T
Revenue (ttm) 51.12T
Net Income (ttm) 5.82T
Shares Out n/a
EPS (ttm) 2,865.68
PE Ratio 20.69
Forward PE 7.39
Dividend 652.40 (3.37%)
Ex-Dividend Date Jul 3, 2025
Volume 91
Average Volume 1,028
Open 20,000
Previous Close 19,375
Day's Range 19,325 - 20,000
52-Week Range 16,875 - 27,225
Beta n/a
RSI 59.43
Earnings Date Jul 31, 2025

About BCBA:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.